Skip to main content
. Author manuscript; available in PMC: 2021 Jan 15.
Published in final edited form as: Clin Cancer Res. 2020 Mar 31;26(14):3803–3818. doi: 10.1158/1078-0432.CCR-19-1895

Figure 5A, Response to Navitoclax. Tumor Growth of PDX1577.

Figure 5A,

Tumor volume was analyzed on the natural log scale to better meet normality assumptions and the predicted mean and standard error of tumor volume over time for each treatment group is shown. Figure 5B, Final Tumor Weight of PDX 1577. Dot plot of tumor weight (g) by treatment (gray line: mean with standard error) Figure 5C, T-ratio Table for PDX tumors Treated with Navitoclax. A t-ratio table for pairwise comparison in tumor growth rate between treatments based on the mixed-effect model with post hoc tests is shown.